|
Volumn 61, Issue 4, 2001, Pages 306-314
|
The clinical significance of tenascin-C splice variant expression in chondrosarcoma
|
Author keywords
Chondrocyte; Chondrosarcoma; Immunohistochemistry; mRNA expression; Reverse transcription polymerase chain reaction; Splice variant; Survival; Tenascin C
|
Indexed keywords
ALGINIC ACID;
TENASCIN;
ADULT;
AGED;
ARTICLE;
CANCER SURVIVAL;
CARCINOMA CELL;
CARTILAGE CELL;
CELL CULTURE;
CELL GROWTH;
CHILD;
CHONDROSARCOMA;
CLINICAL ARTICLE;
CONTROLLED STUDY;
FEMALE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
MALE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN PROCESSING;
PROTEIN VARIANT;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
RNA SPLICING;
TISSUE SECTION;
TUMOR VOLUME;
ADULT;
ALTERNATIVE SPLICING;
BASE SEQUENCE;
BONE NEOPLASMS;
CHILD;
CHONDROSARCOMA;
DNA PRIMERS;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
RNA, MESSENGER;
SURVIVAL RATE;
TENASCIN;
TIME FACTORS;
TRANSCRIPTION, GENETIC;
TUMOR CELLS, CULTURED;
VARIATION (GENETICS);
|
EID: 0035200173
PISSN: 00302414
EISSN: None
Source Type: Journal
DOI: 10.1159/000055338 Document Type: Article |
Times cited : (28)
|
References (43)
|